Journals / Bozok Tıp Dergisi / 2019 / Cilt: 9 - Sayı: 3

Effect of long GnRH Agonist, GnRH Antagonist and Microdose Flare-up Agonist protocols on IVF results in patints with diminished ovarian reserve

AZALMIŞ OVER RESERVİ OLAN OLGULARDA LONG GNRH AGONİST, GNRH ANTAGONİST VE MİKRODOZ FLARE-UP AGONİST PROTOKOLLERİNİN IVF SONUÇLARI ÜZERİNE ETKİSİ

Pages
140–145
Publication Date
2022-10-11
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Overall 713 patints were divided into 3 groups: Group A(n=327) gonadotropin-releasing hormone (GnRH) antagonist protocol, Group B(n=184) long GNRH analog protocol, Group C( n=202) microdose flre-up protocol.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objectie: To compare the effct of gonadotropin-releasing hormone (GnRH) antagonist protocol, microdose flre-up protocol and long GnRH agonist protocol in patints receiving in vitro fertiizatin/ intracytılasmic sperm injectin (IVF/ICSI)treatment due to poor response .
📊
Key Findings & Data:Materials and methods: In a retrospectie study, the records of patints who were poor responders attnding University of Health Sciences Ankara Etlik Zübeyde Hanım Womens Health Applicatin and Research Center, IVF Clinic between January , 2010 and May, 2019 were retrieved.
💡
Conclusion & Impact:Overall 713 patints were divided into 3 groups: Group A(n=327) gonadotropin-releasing hormone (GnRH) antagonist protocol, Group B(n=184) long GNRH analog protocol, Group C( n=202) microdose flre-up protocol.
🔬Design:Research Article
📍Scope:2010 Verileri
⚙️Variables:Domain Parameters

Abstract

Objectie: To compare the effct of gonadotropin-releasing hormone (GnRH) antagonist protocol, microdose flre-up protocol and long GnRH agonist protocol in patints receiving in vitro fertiizatin/ intracytılasmic sperm injectin (IVF/ICSI)treatment due to poor response . Materials and methods: In a retrospectie study, the records of patints who were poor responders attnding University of Health Sciences Ankara Etlik Zübeyde Hanım Womens Health Applicatin and Research Center, IVF Clinic between January , 2010 and May, 2019 were retrieved. Overall 713 patints were divided into 3 groups: Group A(n=327) gonadotropin-releasing hormone (GnRH) antagonist protocol, Group B(n=184) long GNRH analog protocol, Group C( n=202) microdose flre-up protocol. The ovarian stiulatin characteristis as well as the clinical pregnancy rates were compared between groups. Results: Seven hundred and thirteen patints included in the study.Treatment duratin and number of mature oocytes were signifiantly higher in women undergoing the long GnRH agonist regimen compared with Group A and Group C(p=0.001 for both). The cycle cancellatin rate and total gonadotropin dose were signifiantly higher in group C (p=0.001). A signifiant diffrence was not observed with respect to the number of retrieved oocytes . No statitially signifiant diffrences were detected in clinical pregnancy rates between the groups (p=0.337). Conclusion: GnRH antagonist regimen may be preferable to other protocols as it could decrease the cost and treatment duratin in poor responders

Özet

Amaç: Düşük over rezervi tanısıyla IVF programına alınan hastalarda uygulanan mikro doz flre up , GnRHantagonist ve long GnRH agonist gibi farklı protokollerin IVF başarısındaki etkinliğinin karşılaştıılması.Gereç ve yöntemler: Sağlık Bilimleri Üniversitesi Ankara Etlik Zübeyde Hanım Eğiti ve Araştıma HastanesiIVF Kliniğine Ocak 2010 ve Mayıs 2019 tarihleri arasında başvuran ve düşük over reservi tanısı alan hastalarçalışmaya dahil edildi. 713 kadın kullanılan kontrollü ovarian stiulasyon protokellerine göre 3 gruba ayrıldı:Grup A(n=327) GnRH antagonist protokol, Grup B(n=184), long GnRH agonist protokol ve Grup C (n=202)mikrodoz flre-up protokol olarak belirlendi. Gruplar arasında ovarian stiulasyon karekteristileri ve klinikgebelik sonuçları karşılaştııldı.Bulgular:713 olgu çalışmaya dahil edildi. Long GnRH agonist protokol grubu, Grup A ve Grup C ile karşılaş-tııldığında stiulasyon süresi anlamlı olarak daha uzun ve matur oosit sayısı daha fazla bulundu(p=0.001).Total gonadotropin dozu ve siklus iptal oranları grup C de anlamlı olarak yüksektip=0.001).Gruplar arasındatoplanan oosit sayısı açısından anlamlı fark bulunmadı. Klinik gebelik oranları bakımından gruplar arasındaanlamlı fark tespit edilmedi(p=0.337).Sonuç: Düşük over reservi olan kadınlarda tedavi süresini ve maliyet azaltması nedeniyle , GnRH antagonistprotokolü ilk tedavi seçeneği olarak düşünülebilir.

🔖

Cite This Article

DİLBAZ, S., TEKİN, Ö. M., YENİGÜL, N. N., ÖZELÇİ, R., ALDEMİR, O. (2022). Effect of long GnRH Agonist, GnRH Antagonist and Microdose Flare-up Agonist protocols on IVF results in patints with diminished ovarian reserve. Bozok Tıp Dergisi, Cilt: 9 - Sayı: 3, 140–145. https://ajindex.com/articles/468548

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (5)

  1. Keay SD, Liversedge NH, Mathur RS, Jenkins JM. Assisted conceptin following poor ovarian response to gonadotrophin stiulatin. Br J Obstet Gynaecol 1997;104:521-7
  2. Şahin S, Selçuk S, Devranoğlu B, Kutlu T, Kuyucu M, Eroğlu M. Comparison of long GnRH agonist versus GnRH antagonist protocol in poor responders. J Turk Soc Obstet Gynecol 2014;4:203-6 3. Ferraret iP, La Marca A, Fauser JM, Tarlatzis B, Nargund G,Gianaroli L. ESHRE consensus on the defiitin of ‘poor response’ to ovarian stiulatin for in vitro fertiizatin: the Bologna criteria. Hum Reprod 2011;.26( 7): 1616– 1624 4. Humaidan P, Alviggi C, Fischer R, Esteves SC. The novel POSEIDON stratiiatin of ‘Low prognosis patints in Assisted Reproductie Technology’ and its proposed marker of successful outcome. F1000Research 2016, 5:2911 5. Cohen J, Chabbert-Bufft N, Darai E. Diminished ovarian reserve, premature ovarian failure, poor ovarian responder—a plea for universal defiitins. J Assist Reprod Genet 2015; 32: 1709–171 6. Lambalk CB, Banga1 FR, Huirne JA, Toftger M, Pinborg A, Homburg R et al. GnRH antagonist versus long agonist protocols in IVF: a systemati review and meta-analysis accountig for patint type. Hum Reprod Update 2017; 23(5):560–579 7. Berin I, Stein DE, Keltz MD. A comparison of gonadotropinreleasing hormone (GnRH) antagonist and GnRH agonist flre protocols for poor responders undergoing in vitro fertiizatin. Ferti Steril 2010;93:360–3
  3. Kahraman K, Berker B, Atabekoglu CS, Sonmezer M, Cetikaya E, Aytac R et al. Microdose gonadotropin-releasing hormone agonist flre-up protocol versus multile dose gonadotropin-releasing hormone antagonist protocol in poor responders undergoing intracytoplasmic sperm injectin–embryo transfer cycle. Ferti Steril 2009;91:2437–44
  4. Prapas Y, Petousis S, Dagklis T, PanagiotiisY, Papatheodorou A, Assunta I et al. GnRH antagonist versus long GnRH agonist protocol in poor IVF responders:a randomized clinical trial. Eur J Obstet Gynecol and Reprod Biol 2013;166: 43–46 10. Merviel P, Cabry-Goubet R, Lourdel E, Devaux A, BelhadriMansouri N, Copin H et al. Comparatie prospectie study of 2 ovarian stiulatin protocols in poor responders: effct on implantatin rate and ongoing pregnancy. Reprod Health 2015; 12:52 11. Cheung LP, Lam PM, Lok IH, Chiu TT, Yeung SY, Tjer CC, Haines CJ. GnRH antagonist versus long GnRH agonist protocol in poor responders undergoing IVF: a randomized controlled trial. Hum Reprod 2005;20:616-21
  5. Sunkara SK, Coomarasamy A, Faris R,